Ikaria Bioscience Pty Ltd
Clinical trials sponsored by Ikaria Bioscience Pty Ltd, explained in plain language.
-
New obesity drug combo tested in early trial
Disease control Recruiting nowThis study tests a new drug called RN3161, given alone or with another weight loss drug (tirzepatide), in adults with overweight or obesity. The goal is to check safety and how the body handles the drug. About 104 people will take part, and the study is currently recruiting.
Phase: PHASE1, PHASE2 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated May 26, 2026 08:24 UTC
-
New cholesterol drug RN5681 enters first human safety trial
Disease control Recruiting nowThis early-stage study tests a single dose of the experimental drug RN5681 in 60 healthy adults with high cholesterol. The main goal is to check safety and how the body processes the drug. Researchers will also look at changes in cholesterol levels over time. Participants receive…
Phase: PHASE1 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated May 22, 2026 13:52 UTC